Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03459963
Other study ID # elgammal
Secondary ID
Status Active, not recruiting
Phase N/A
First received February 28, 2018
Last updated March 8, 2018
Start date May 18, 2017
Est. completion date April 1, 2018

Study information

Verified date March 2018
Source Ain Shams Maternity Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aims to compare the routine use versus non-use of urethral catheterization in women undergoing first elective cesarean section as regard to intraoperative and postoperative complications


Description:

This randomized controlled trial will be done at Ain Shams University Maternity One hundred and seventy pregnant women scheduled for first elective CS attending at outpatient clinic will be chosen after complete history and physical examination to determine eligibility for inclusion after taking their consent with full explanation of the study including potential benefits and risks.

The study population will be randomized using computer sequence program in 1:1 ratio. Allocation of every patient to one of the studied groups will be done using opaque envelops.

The studied groups will be either Group C or Group N For both groups

- A written consent will be taken.

- Full history to exclude medical problems that need special care.

- Full history to exclude UTI or recurrent UTI during pregnancy.

- A single dose of 2 gm cefazolin will be given IV pre-incision for preoperative antibiotic prophylaxis (Sullivan et al., 2007).

- midstream urine samples will be collected preoperative to exclude UTI and 24 hours postoperatively after giving the instructions to the patients (washing hands and genitals ,pass some urine into the toilet then without stopping catch some urine in a sterile container ) to be analyzed for presence of UTI


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 170
Est. completion date April 1, 2018
Est. primary completion date December 20, 2017
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria:

- Pregnant women undergoing first elective CS at term pregnancy (37-41w gestation).

- haemodynamically stable

Exclusion Criteria:

- History of recurrent UTI during pregnancy, current UTI

- presence of Medical complications that requiring special care e.g: diabetes with pregnancy, hypertensive disorders with pregnancy, cardiac disease, chronic renal disease,

- previous cesarean section

- Previous abdominal surgery which may be associated with extensive adhesions, -polyhydraminos

- fetal macrosomia

- significant vaginal bleeding

- Contraindication for the antibiotic used e.g: anaphylaxis

- Need for extensive use of antibiotics more than the prophylactic dose

- Spinal anesthesia.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
indwelling urinary catheter
85 women undergoing first elective CS will be catheterized immediately preoperatively using Foley's catheter by applying catheterization precautions.

Locations

Country Name City State
Egypt Ain Shams University Maternity Hospital. Cairo

Sponsors (2)

Lead Sponsor Collaborator
Ain Shams Maternity Hospital World Health Organization

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Presence of UTI midstream urine samples were collected 24 hours postoperatively after giving the instructions to the patients and tested for presence of UTI. These fresh non-centrifuged urine samples were collected and tested for leukocyte esterase and nitrite using (Convergys urine matrix 10, Germany) strips. Nitrite will be considered positive if there is change in color of dipstick from colorless towards pink within 60 seconds. Leukocyte esterase will be considered positive if there is change in color from off-white towards purple within 2 minutes 24-h postoperative
Secondary Operative duration The time taken for surgery from skin opening to complete skin closure, intraoperative
Secondary Bladder injury incidence. accidental bladder injury during operation intraoperative
Secondary Intraoperative need of urethral catheter in N group intraoperative need of catheter for any reason intraoperative
Secondary Ambulation time from intraoperative skin opening time till the patient is able to move. intraoperative
Secondary Postpartum hemorrhage identified when there is costant trickling f blood or repeated soakage of valval pad within 5 minutes first postoperative day
Secondary Urinary retention defined as no spontaneous micturition >24 hours after cesarean delivery first postoperative day
Secondary Patient satisfaction using four point likert scale from 1-4 (as 1 = not satisfied, 2 = partial satisfied, 3 = satisfied, 4 = very satisfied). second postoperative day morning
See also
  Status Clinical Trial Phase
Terminated NCT00804557 - Efficacy And Safety Of The Uro-Ease® Urinary Catheter During Clean Intermittent Catheterization N/A
Suspended NCT06217016 - Effect of ICCAUT Strategy on Postoperative Urinary Retention After Radical Rectal Cancer Surgery (ICCAUT-2) N/A
Recruiting NCT06241703 - Effect of ICCAUT Strategy on Postoperative Urinary Dysfunction After Radical Rectal Cancer Surgery N/A
Not yet recruiting NCT04159077 - REduction of Post-Operative Urinary Retention With Tamsulosin Versus Placebo (REPOURT- P) Trial Phase 3
Completed NCT00753298 - A Randomized, Fully-blinded Parallel Groups Study of Catheter Materials Used for Clean Intermittent Catheterisation N/A
Withdrawn NCT01063452 - Impact of Atkinson Product Design Urinary Slide Valve Versus Standard Catheter Drainage System on Social Functioning Phase 4
Not yet recruiting NCT05710731 - The Urinary Catheterization Training on Skills, Satisfaction and Self-Confidence in Nursing Students N/A
Completed NCT00748033 - A Study Evaluating a Urinary Catheter With Different Activation Times for the Wetting Solution, in Healthy Male Volunteers. N/A